雅本化学(300261) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was ¥219,942,064.63, a decrease of 54.06% compared to ¥478,738,677.64 in the same period last year[5] - The net loss attributable to shareholders was ¥45,576,667.50, representing a decline of 185.65% from a profit of ¥53,215,317.80 in the previous year[5] - Basic and diluted earnings per share were both -¥0.0475, a decrease of 185.28% from ¥0.0557 in the same period last year[5] - The net profit for the first quarter of 2024 was -44,286,323.71 CNY, compared to a net profit of 52,294,452.98 CNY in the same period last year, representing a significant decline[20] - The company reported a total comprehensive income of -57,137,857.45 CNY for the first quarter, compared to 57,873,413.39 CNY in the same quarter last year[21] Cash Flow and Liquidity - The net cash flow from operating activities was ¥6,343,271.16, down 94.09% from ¥107,265,279.07 in Q1 2023[5] - The cash and cash equivalents at the end of the period were 314,720,829.76 CNY, down from 451,657,264.02 CNY at the end of the previous year, a decrease of approximately 30.3%[24] - The company incurred a loss of -50,531,001.17 CNY in operating profit, contrasting with an operating profit of 61,431,600.21 CNY in the same quarter last year[20] - The company's investment activities resulted in a net cash outflow of -34,739,365.09 CNY, compared to -59,915,264.87 CNY in the previous year, showing an improvement in cash flow management[24] - The financing activities generated a net cash inflow of 117,285,445.73 CNY, significantly higher than 25,835,029.21 CNY in the same period last year, indicating increased financing efforts[24] Assets and Liabilities - Total assets at the end of Q1 2024 were ¥4,192,018,181.26, an increase of 1.13% from ¥4,145,222,725.41 at the end of the previous year[5] - Total liabilities increased to CNY 1,777,396,469.51 from CNY 1,717,475,770.19, marking a rise of 3.5%[18] - The company's equity attributable to shareholders decreased to CNY 2,258,389,004.97 from CNY 2,274,817,267.89, a decline of 0.7%[18] Research and Development - The company's R&D expenses decreased by 30.36% to ¥19,379,345.49 from ¥27,826,005.82 in Q1 2023[9] - Research and development expenses for Q1 2024 were CNY 19,379,345.49, down 30.4% from CNY 27,826,005.82 in the previous year[19] Shareholder Information - The total number of common shareholders at the end of the reporting period is 80,029[11] - Ningbo Yabao Holdings holds 26.75% of shares, totaling 257,729,839 shares[11] - The company has a new employee stock ownership plan for 2023, holding 8,623,900 shares[11] - The company has 6.75% of shares held by foreign individual shareholder Wang Xinya, totaling 65,000,350 shares[11] - The company has 2.91% of shares held by Zhang Yuxin, totaling 28,010,000 shares[11] - The company has 2.53% of shares held by Cai Tong, totaling 24,376,051 shares, with 18,282,038 shares under pledge[11] - The company has 0.73% of shares held by Jin Xiangguo and Liao Guopei, each totaling 7,000,000 shares[11] Legal Matters - The company has 43 ongoing lawsuits with a total amount involved of 2,593,035,000 CNY, which will not significantly impact financial statements[13] - The company has paid 2,383,525.20 CNY in relation to a judgment that has come into effect[13] Investment Income - The company reported a significant decrease in investment income, down 50.03% to ¥941,210.32 from ¥1,883,366.72 in the same period last year[9] - The company reported an investment income of CNY 941,210.32, a decrease of 50.0% compared to CNY 1,883,366.72 in the same period last year[19] Fair Value Changes - The company experienced a 240.07% decline in fair value changes, reporting a loss of ¥6,655,670.00 compared to a gain of ¥4,751,745.00 in the previous year[9] Accounts Receivable and Inventory - Accounts receivable decreased to CNY 511,030,145.46 from CNY 573,663,679.59, a decline of 10.9%[16] - Inventory increased to CNY 614,976,811.90 from CNY 587,282,262.37, reflecting a rise of 4.7%[16]